Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$5.12M Buy
93,824
+1,855
+2% +$102K 2.44% 16
2015
Q1
$5M Buy
91,969
+855
+0.9% +$43.1K 2.38% 16
2014
Q4
$4.25M Buy
91,114
+1,305
+1% +$61.1K 2.02% 23
2014
Q3
$4.12M Buy
89,809
+810
+0.9% +$37.9K 2.05% 19
2014
Q2
$4.12M Buy
88,999
+890
+1% +$41.9K 2.05% 19
2014
Q1
$4.09M Buy
88,109
+3,645
+4% +$159K 2.14% 17
2013
Q4
$3.48M Buy
84,464
+670
+0.8% +$26.4K 1.86% 20
2013
Q3
$3.07M Sell
83,794
-7,411
-8% -$280K 1.76% 22
2013
Q2
$3.38M Buy
+91,205
New +$3.26M 1.91% 23

Other funds holding DOX

Laidlaw Group's DOX Position: Q2 2015 in Review

Laidlaw Group increased its Amdocs (DOX) stake by 2% in Q2 2015, buying an estimated $102K and bringing the position to 93,824 shares worth $5.12M. The position accounts for 2.44% of the portfolio, ranked #16.

Laidlaw Group first reported a position in DOX in Q2 2013 and has held it in 9 quarters since. 325 funds tracked by Wall St. Rank hold DOX as of Q2 2015.

  • Laidlaw Group held 93,824 shares of Amdocs worth $5.12M as of Q2 2015.
  • Laidlaw Group bought 1,855 Amdocs shares in Q2 2015, an estimated $102K.
  • Amdocs made up 2.44% of Laidlaw Group's portfolio in Q2 2015, its #16 holding.
  • Laidlaw Group first reported a position in Amdocs in Q2 2013 and has held it in 9 quarters since.
  • 325 funds tracked by Wall St. Rank held Amdocs as of Q2 2015.

Based on Laidlaw Group's 13F filing for Q2 2015, filed 31 Jul 2015.